Eledon Pharmaceuticals, Inc. (ELDN)
3.20
-0.12
(-3.61%)
USD |
NASDAQ |
Aug 28, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
Eledon Pharmaceuticals Free Cash Flow : -73.86M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -73.86M |
| March 31, 2026 | -68.89M |
| December 31, 2025 | -62.34M |
| September 30, 2025 | -67.24M |
| June 30, 2025 | -64.53M |
| March 31, 2025 | -54.59M |
| December 31, 2024 | -47.27M |
| September 30, 2024 | -37.42M |
| June 30, 2024 | -37.90M |
| March 31, 2024 | -38.34M |
| December 31, 2023 | -39.53M |
| September 30, 2023 | -39.88M |
| June 30, 2023 | -32.20M |
| March 31, 2023 | -30.19M |
| December 31, 2022 | -28.42M |
| September 30, 2022 | -28.15M |
| June 30, 2022 | -30.67M |
| March 31, 2022 | -31.90M |
| December 31, 2021 | -28.91M |
| September 30, 2021 | -29.14M |
| June 30, 2021 | -22.61M |
| March 31, 2021 | -18.18M |
| December 31, 2020 | -15.21M |
| September 30, 2020 | -7.802M |
| Date | Value |
|---|---|
| June 30, 2020 | -10.13M |
| March 31, 2020 | -12.03M |
| December 31, 2019 | -13.86M |
| September 30, 2019 | -15.19M |
| June 30, 2019 | -15.23M |
| March 31, 2019 | -13.64M |
| December 31, 2018 | -11.89M |
| September 30, 2018 | -11.15M |
| June 30, 2018 | -11.63M |
| March 31, 2018 | -16.33M |
| December 31, 2017 | -14.94M |
| September 30, 2017 | -13.61M |
| June 30, 2017 | -11.67M |
| March 31, 2017 | 3.943M |
| December 31, 2016 | -4.932M |
| September 30, 2016 | -12.75M |
| June 30, 2016 | -21.67M |
| March 31, 2016 | -40.41M |
| December 31, 2015 | -41.80M |
| September 30, 2015 | -39.17M |
| June 30, 2015 | -33.23M |
| March 31, 2015 | -27.51M |
| December 31, 2014 | -21.15M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.796B |
| Viking Therapeutics, Inc. | -418.44M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.68M |
| Cash from Investing (Quarterly) | 23.24M |
| Cash from Financing (Quarterly) | 0.091M |
| Free Cash Flow Per Share (Quarterly) | -0.1996 |
| Free Cash Flow to Equity (Quarterly) | -22.59M |
| Free Cash Flow to Firm (Quarterly) | -22.68M |
| Free Cash Flow Yield | -24.38% |